Explore MMB-FUBINACA | TiHKAL · info

Exploring MMB-FUBINACA. To explore a different substance…

Names

AMB-FUBINACA
MMB-FUBINACA
FUB-AMB

IUPAC names

Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate
Methyl N-{1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}-L-valinate

ID 4522 · Formula C₂₁H₂₂FN₃O₃ · Molecular weight 383.416

Tags Cannabinoid

InChI InChI=1S/C21H22FN3O3/c1-13(2)18(21(27)28-3)23-20(26)19-16-6-4-5-7-17(16)25(24-19)12-14-8-10-15(22)11-9-14/h4-11,13,18H,12H2,1-3H3,(H,23,26)/t18-/m0/s1

InChI Key FRFFLYJQPCIIQB-SFHVURJKSA-N This stereoisomer Any stereoisomer

SMILES COC(=O)[C@H](C(C)C)NC(=O)c1nn(c2c1cccc2)Cc1ccc(cc1)F

ChemSpider 32741679
PubChem 119026173
Wikidata Q27290479
Wikipedia AMB-FUBINACA
Project Response 1387-15
forensicdrugreview.com FUB-AMB

Longworth, M; Banister, SD; Boyd, R; Kevin, RC; Connor, M; McGregor, IS; Kassiou, M. The pharmacology of cumyl-carboxamide synthetic cannabinoid new psychoactive substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and their analogues. ACS Chem. Neurosci., 9 Aug 2017, 8 (10), 2159-2167. 1.1 MB. https://doi.org/10.1021/acschemneuro.7b00267 #7

EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.

Hess, C; Murach, J; Krueger, L; Scharrenbroch, L; Unger, M; Madea, B; Sydow, K. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples. Drug Test. Analysis, 1 May 2017, 9 (5), 721-733. 267 kB. https://doi.org/10.1002/dta.2030 #FUB AMB LC,MS

Abbate, V; Schwenk, M; Presley, BC; Uchiyama, N. The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report). Pure Appl. Chem., 28 Aug 2018, 90 (8), 1255–1282. 1.0 MB. https://doi.org/10.1515/pac-2017-0605 #8. MMB-FUBINACA

Banister, SD; Connor, M. The chemistry and pharmacology of synthetic cannabinoid receptor agonist new psychoactive substances: Evolution. In New Psychoactive Substances : Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 191-226. 1.2 MB. https://doi.org/10.1007/164_2018_144 #76

Banister, SD; Adams, A; Kevin, RC; Macdonald, C; Glass, M; Boyd, R; Connor, M; McGregor, IS; Havel, CM; Bright, SJ; Vilamala, MV; Lladanosa, CG; Barratt, MJ; Gerona, RR. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA. Drug Test. Analysis, 1 Feb 2019, 11 (2), 279–291. 3.1 MB. https://doi.org/10.1002/dta.2491 #AMB-FUBINACA GC,MS,NMR

Banister, SD; Arnold, JC; Connor, M; Glass, M; McGregor, IS. Dark classics in chemical neuroscience: Δ⁹-Tetrahydrocannabinol. ACS Chem. Neurosci., 15 May 2019, 10 (5), 2160–2175. 1.8 MB. https://doi.org/10.1021/acschemneuro.8b00651 #12

MEP-FUBINACA

7 Dec 2019 · · Isomer Design